Ken Griffin Opti Nose, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Opti Nose, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 39,048 shares of OPTN stock, worth $27,724. This represents 0.0% of its overall portfolio holdings.

Number of Shares

39,048

Previous 103,473 62.26%

Holding current value

$27,724

Previous $151,000 73.51%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.82 - $1.44 $52,828 - $92,772	-64,425 Reduced 62.26%	39,048 $40,000
Q1 2024 May 15, 2024	BUY	$1.17 - $1.94 $91,084 - $151,029	77,850 Added 303.83%	103,473 $151,000
Q4 2023 Feb 14, 2024	BUY	$1.02 - $1.47 $26,135 - $37,665	25,623 New	25,623 $33,000
Q1 2023 May 15, 2023	SELL	$1.63 - $2.02 $18,673 - $23,141	-11,456 Reduced 37.62%	18,997 $36,000
Q4 2022 Feb 14, 2023	BUY	$1.68 - $3.7 $28,726 - $63,266	17,099 Added 128.04%	30,453 $56,000
Q3 2022 Nov 14, 2022	SELL	$3.43 - $4.01 $20,281 - $23,711	-5,913 Reduced 30.69%	13,354 $49,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.82 $11,883 - $25,792	-6,752 Reduced 25.95%	19,267 $70,000
Q1 2022 May 16, 2022	BUY	$1.77 - $2.93 $14,496 - $23,996	8,190 Added 45.94%	26,019 $64,000
Q3 2021 Nov 15, 2021	BUY	$2.35 - $3.16 $41,898 - $56,339	17,829 New	17,829 $53,000
Q3 2020 Nov 16, 2020	SELL	$3.69 - $7.09 $284,868 - $547,348	-77,200 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$3.58 - $7.44 $97,787 - $203,223	-27,315 Reduced 26.14%	77,200 $574,000
Q1 2020 May 15, 2020	SELL	$3.49 - $9.2 $55,452 - $146,178	-15,889 Reduced 13.2%	104,515 $469,000
Q4 2019 Feb 14, 2020	BUY	$6.27 - $11.41 $4,301 - $7,827	686 Added 0.57%	120,404 $1.11 Million
Q3 2019 Nov 14, 2019	BUY	$4.75 - $8.38 $320,625 - $565,650	67,500 Added 129.27%	119,718 $838,000
Q2 2019 Aug 14, 2019	SELL	$6.4 - $10.94 $70,496 - $120,504	-11,015 Reduced 17.42%	52,218 $370,000
Q1 2019 May 15, 2019	SELL	$6.1 - $10.3 $27,108 - $45,773	-4,444 Reduced 6.57%	63,233 $0
Q4 2018 Feb 14, 2019	SELL	$5.84 - $11.92 $177,781 - $362,868	-30,442 Reduced 31.03%	67,677 $419,000
Q3 2018 Nov 13, 2018	BUY	$12.43 - $29.76 $1.22 Million - $2.92 Million	98,119 New	98,119 $0

Others Institutions Holding OPTN

# of Institutions

Shares Held

85.9M

Call Options Held

Put Options Held

View Full List

About OptiNose, Inc.

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $59.1M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

More about OPTN

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account